Mind the gap in kidney care: translating what we know into what we do

Historically, it takes an average of 17 years for new treatments to move from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. Now is the time to narrow the gap between what we kno...

Full description

Saved in:
Bibliographic Details
Published in:Brazilian journal of medical and biological research 2024-08, Vol.57
Main Authors: Luyckx, V.A, Tuttle, K.R, Abdellatif, D, Correa-Rotter, R, Fung, W.W.S, Haris, A, Hsiao, L.L, Khalife, M, Kumaraswami, L.A, Loud, F, Raghavan, V, Roumeliotis, S, Sierra, M, Ulasi, I, Wang, B, Lui, S.F, Liakopoulos, V, Balducci, A
Format: Article
Language:English
Subjects:
Care and treatment
Chronic kidney failure
Dapagliflozin
Development and progression
Diabetes therapy
Evidence-based medicine
Health care reform
Hypertension
Medical care
Pharmaceutical industry
Prevention
Primary nursing
Public health
Risk factors
Social aspects
Type 2 diabetes
United States
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Historically, it takes an average of 17 years for new treatments to move from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. Now is the time to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions are diagnosed worldwide, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because it is often silent in the early stages. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from the patient to the clinician to the health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay Key words: Chronic kidney disease; Equity; Kidney care; Public health; World Kidney Day
ISSN:0100-879X
DOI:10.1590/1414-431X2024e14073